Bluenote is an AI Platform company specialized in transforming life sciences workflows. Their mission is to bring life-saving medicines, medical devices, and diagnostics to patients and clinicians sooner by streamlining regulatory and compliance workflows.
The company has developed a generative AI technology platform that helps life sciences organizations automate and streamline regulatory workflows. Their platform is particularly focused on producing regulatory filings, technical reports, protocols, Standard Operating Procedures (SOPs), validation reports, risk analyses, and manufacturing documentation. Their technology features advanced capabilities such as optimized RAG (Retrieval-Augmented Generation), agentic workflow orchestration, and intelligent model routing.
Built with robust security and privacy standards, Bluenote's platform complies with HIPAA, GDPR, SOC2, CLIA, and CAP requirements. The company maintains a strict data policy with zero data retention for LLMs and offers on-premise hosting options for maximum control over data.
Backed by notable investors including Lux Capital and Elad Gil, Bluenote has deployed over 15 applications for scientists, engineers, quality, regulatory and manufacturing teams. Their platform features fine-tuned models that are 90% preferred over off-the-shelf models, combining the best capabilities from various providers including Anthropic, OpenAI, and Google, along with their own proprietary models.